Don Sin

COPD

• QRISK3 underestimates the risk of cardiovascular events in patients with COPD
• A Cost-Effectiveness Analysis of Azithromycin for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
• The hidden and unchecked judgement calls when using exacerbation history for managing COPD
• Benefit-harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease
• A personalized biomedical risk assessment infographic for people who smoke with COPD: a qualitative study
• ACCEPT 2·0: Recalibrating and externally validating the Acute COPD exacerbation prediction tool (ACCEPT)
• Generalizability of risk stratification algorithms for exacerbations in COPD
• The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline
• Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?
• Predicting Severe COPD Exacerbations: Developing a Population Surveillance Approach with Administrative Data
• Statin use and lung cancer risk in chronic obstructive pulmonary disease patients: a population-based cohort study
• The diagnostic performance of patient symptoms in screening for COPD
• Predicting severe COPD exacerbations: A population surveillance approach with administrative data
• An individualized prediction model for long-term lung function trajectory and risk of COPD in the general population

MISCELLANEOUS

• Trends in hospital admissions for chronic obstructive pulmonary disease over 16 years in Canada

IMPACT

• IMplementing Predictive Analytics towards efficient COPD Treatments (IMPACT): protocol for a stepped-wedge cluster randomized impact study.

CPM

• Moving beyond AUC: decision curve analysis for quantifying net benefit of risk prediction models

ACCEPT

• The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study

EPIC

• Cost-Effectiveness of Case Detection Strategies for the Early Detection of COPD

ASTHMA

• The economic burden of multimorbidity in severe asthma patients: a 20-year population-based study
• Long-Term Trajectories of Mild Asthma in Adulthood and Risk Factors of Progression

METHODOLOGY

• Lowering the P Value Threshold